We are live on ! Find out more
JG

Jefferies Group Portfolio holdings

AUM $12B
1-Year Est. Return 6.2%
This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
-6.2%
3 Year Est. Return
+88.85%
5 Year Est. Return
+123.14%
10 Year Est. Return
AUM
$19.4B
AUM Growth
+$1.45B
Cap. Flow
+$1.27B
Cap. Flow %
6.57%
Top 10 Hldgs %
32.14%
Holding
3,720
New
1,674
Increased
652
Reduced
743
Closed
445

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$182M
2
KCG
KCG Holdings, Inc.
KCG
+$85.1M
3
EBAY icon
eBay
EBAY
+$78.6M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$71.1M
5
AGN
Allergan plc
AGN
+$64.1M

Sector Composition

Rank Sector Weight
1 Healthcare 2.37%
2 Consumer Discretionary 1.84%
3 Technology 1.55%
4 Energy 1.37%
5 Industrials 1.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LHO
2101
DELISTED
LaSalle Hotel Properties
LHO
$111K ﹤0.01%
+3,122
New +$115K
ZOES
2102
CALL
DELISTED
Zoe's Kitchen, Inc.
ZOES
$111K ﹤0.01%
+2,700
New +$94.2K
KRE icon
2103
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
$110K ﹤0.01%
+2,500
New +$106K
MRSH
2104
Marsh
MRSH
$86.3B
$110K ﹤0.01%
+1,932
New +$112K
BTU
2105
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
$110K ﹤0.01%
3,333
-492
-13% -$28.8K
CALX icon
2106
CALL
Calix
CALX
$2.27B
$109K ﹤0.01%
14,300
-27,700
-66% -$226K
HIMX
2107
Himax Technologies
HIMX
$2.2B
$109K ﹤0.01%
+13,620
New +$92.6K
HOUS
2108
DELISTED
Anywhere Real Estate
HOUS
$109K ﹤0.01%
+2,350
New +$109K
CMD
2109
DELISTED
Cantel Medical Corporation
CMD
$109K ﹤0.01%
+2,032
New +$98.8K
KERX
2110
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$109K ﹤0.01%
+10,900
New +$117K
SALE
2111
DELISTED
RetailMeNot, Inc. Series 1
SALE
$109K ﹤0.01%
6,105
+5,833
+2,144% +$112K
MAS icon
2112
Masco
MAS
$16B
$108K ﹤0.01%
4,626
-10,072
-69% -$238K
PFF icon
2113
iShares Preferred and Income Securities ETF
PFF
$13.2B
$108K ﹤0.01%
+2,754
New +$109K
BCO icon
2114
Brink's
BCO
$5.02B
$107K ﹤0.01%
+3,623
New +$110K
HLX icon
2115
Helix Energy Solutions
HLX
$1.46B
$107K ﹤0.01%
8,414
-8,526
-50% -$134K
IART icon
2116
Integra LifeSciences
IART
$1.54B
$107K ﹤0.01%
+3,868
New +$103K
KMB icon
2117
Kimberly-Clark
KMB
$36.4B
$107K ﹤0.01%
1,007
+925
+1,128% +$101K
DEI icon
2118
Douglas Emmett
DEI
$2.06B
$106K ﹤0.01%
3,914
-19,824
-84% -$574K
SAIC icon
2119
Saic
SAIC
$5.03B
$106K ﹤0.01%
2,005
-4,129
-67% -$216K
ONIT
2120
Onity Group
ONIT
$333M
$106K ﹤0.01%
696
-5,239
-88% -$762K
SRC
2121
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$106K ﹤0.01%
2,446
-1,190
-33% -$59.4K
BTU
2122
PUT
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
$106K ﹤0.01%
3,220
CKH
2123
DELISTED
Seacor Holdings Inc.
CKH
$106K ﹤0.01%
1,541
-1,527
-50% -$106K
GL icon
2124
Globe Life
GL
$13.5B
$105K ﹤0.01%
+1,810
New +$103K
SHY icon
2125
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$105K ﹤0.01%
+1,243
New +$105K

Similar funds

Jefferies Group's Q2 2015 Portfolio in Review

As of Q2 2015, Jefferies Group held 3,720 positions worth $19.4B, up 8.1% from $17.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jefferies Group deployed $1.27B of net new capital in Q2 2015, opening 1,674 new positions and adding to 652 existing holdings. Its largest new stake was El Pollo Loco: 3,675,000 shares worth $76.1M.

By sector, the portfolio is most concentrated in Healthcare at 2.4% of assets, down from 3.8% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Viatris, an estimated $182M trimmed.

  • Jefferies Group's largest Q2 2015 buy was El Pollo Loco: 3,675,000 shares worth $76.1M.
  • Jefferies Group added most to iShares Russell 2000 ETF in Q2 2015, an estimated $219M increase.
  • Jefferies Group's biggest Q2 2015 reduction was Viatris, cutting an estimated $182M.
  • Jefferies Group fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $26.4M.
  • Jefferies Group's ten largest holdings make up 32% of its $19.4B portfolio in Q2 2015.
  • Jefferies Group opened 1,674 new positions and closed 445 in Q2 2015.
  • Jefferies Group's portfolio value rose 8.1% quarter-over-quarter to $19.4B.

Based on Jefferies Group's 13F filing for Q2 2015, filed 18 Aug 2015.